IP Library Patent Application 13451429
Patent Application
App. No. 13/451,429

METHODS AND APPARATUSES FOR MANUFACTURING A PLURALITY OF CARTRIDGES OF MEDICAL BUFFERING SOLUTION WITH A COMMON PH

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/451,429
Abstract

The pH of a buffer or other medical solution in a plurality of containers can be adjusted and maintained by partially filling each container with a sodium bicarbonate solution so that a headspace remains over the solution. The headspace is filled with gas having a known CO 2 concentration, and a fixed and precise pH will result after the CO 2 is dissolved and the solution fully equilibrates.

Claims (13)

1 . A method for adjusting the pH of a medical solution in a container, said method comprising:

filling the container with a preselected volume of a bicarbonate solution to leave a predetermined volume of headspace over the buffer;

filling the headspace with a CO 2 -rich gas;

sealing the container to allow the CO 2 -rich gas to dissolve in the buffer to adjust a pH of the buffer to a desired value.

2 . A method as in claim 1 , wherein the volume of bicarbonate buffer is in the range from 1.6 ml to 2.1 ml and the headspace volume is in the range from 0.16 ml to 0.21 ml.

3 . A method as in claim 1 , wherein the CO 2 -rich gas has a CO 2 concentration of at least 75%.

4 . A method as in claim 3 , wherein the CO 2 concentration is at least 98%.

5 . A method as in claim 1 , wherein the contents of the container are maintained at ambient pressure after sealing.

6 . A method as in claim 5 , wherein the cartridge has a moveable plug.

7 . A method as in claim 1 , wherein the contents of the container are maintained at a pressure above ambient after sealing.

8 . A method as in claim 7 , wherein the container has a moveable plug and the pressure is maintained by applying a spring-force to the plug.

9 . A method as in claim 1 , further comprising holding the containers in a controlled atmosphere after filling, but before sealing so that the buffer pre-equilibrates with the atmosphere.

10 . A method as in claim 9 , wherein the controlled atmosphere comprises the CO 2 -rich gas, wherein the headspace fills with the CO 2 -rich gas while the buffer pre-equilibrates.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Dec 3, 2014
From: ONPHARMA INC
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 034524/0018 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2013
From: STEPOVICH, MATTHEW J.; NGUYEN, HARRY
To: ONPHARMA, INC.
Reel/Frame 030164/0639 →